A randomized, double-blind, placebo-controlled clinical trial evaluating Dermytol(®) cream for the treatment of actinic keratoses.

Clin Cosmet Investig Dermatol · 2014 · PMC4132222 · PMID 25143750

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a trend toward significanceP =0.06so close (0.05 < p ≤ 0.1)

A greater proportion of participants in the CPA group than the placebo group showed a >10% decrease in average lesion size at week 3 ( P =0.05) and week 6 ( P =0.02) and showed a trend toward significance at week 12 ( P =0.06) ( Figure 4 ).

also in 2,500 other papers

showed a trendP =0.06so close (0.05 < p ≤ 0.1)

Furthermore, the proportion of participants with a $10% decrease in average lesion area was significantly higher in the CPA group than the placebo group at weeks 3 ( P =0.05) and 6 ( P =0.02), and showed a trend at week 12 ( P =0.06).

also in 33,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.